Harmony Biosciences Holdings Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Adjusted EPS Results. The Company Acquired Epygenix Therapeutics
Harmony Biosciences Holdings公布的第一季度调整后每股收益好于预期后,该公司股价走高。该公司收购了Epygenix Therapeutics